Histone deacetylases
Showing 1 - 25 of 217
Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston
Recruiting
- Heart Failure With Normal Ejection Fraction
- +3 more
- 11C-Martinostat
- PET-MRI
-
Boston, MassachusettsMassachusetts General Hospital
Mar 1, 2022
Hematuria, Bladder Cancer Trial in Syracuse (Valproic Acid)
Completed
- Hematuria
- Bladder Cancer
- Valproic Acid
-
Syracuse, New YorkSUNY Upstate Medical University
Oct 19, 2021
Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)
Recruiting
- Malignant Neoplasm
- Malignant Neoplasm of Brain
- NBM-BMX Capsule
- +2 more
-
Hualien City, Taiwan
- +4 more
Aug 22, 2023
Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)
Not yet recruiting
- Polycystic Ovary Syndrome
- laparoscopy / laparotomy
- NO INTERVENTION
-
Hyderabad, Telangana, IndiaDr. Shraddha Ramchandani
Oct 25, 2023
Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)
Completed
- Breast Cancer
- Estrogen Receptor Positive Breast Cancer
-
Denver, Colorado
- +2 more
Dec 14, 2021
HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)
Recruiting
- HIV-1-infection, Subtype b
- Decitabine cycle 1
- +7 more
-
Bruxelles, Belgium
- +2 more
Jan 30, 2023
Bacterial Vaginosis Trial in India (Lactobacillus Species, Placebo)
Recruiting
- Bacterial Vaginosis
- Lactobacillus Species
- Placebo
-
Jaipur, Maharashtra, India
- +4 more
Apr 29, 2022
Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)
Active, not recruiting
- Chronic Myeloproliferative Neoplasms
-
Berlin, Germany
- +14 more
Jun 14, 2021
Hodgkin's Lymphoma Trial in Milano (ITF2357)
Completed
- Hodgkin's Lymphoma
-
Milano, ItalyIstituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021
Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)
Terminated
- Leiomyosarcoma
- +2 more
- Vorinostat Oral Capsule
-
Graz, AustriaMedical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020
De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Terminated
- De Novo Autoimmune Hepatitis
- Pediatric transplant subject with d-AIH
- +6 more
- (no location specified)
Dec 9, 2021
HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)
Not yet recruiting
- HCC
- Zabadinostat (CXD101) and Geptanolimab
- Lenvatinib and Sorafenib
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
May 15, 2023
Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous
Recruiting
- Recurrent Anaplastic Large Cell Lymphoma
- +8 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 6, 2022
Osteosarcoma Trial (Tucidinostat, Apatinib)
Not yet recruiting
- Osteosarcoma
- Tucidinostat, Apatinib
- (no location specified)
Nov 5, 2023
Mindfulness, Compassion, Psychophysiologic Reaction Trial in Madrid (Mindfulness-Based Stress Reduction, Compassion Cultivation
Recruiting
- Mindfulness
- +5 more
- Mindfulness-Based Stress Reduction
- Compassion Cultivation Training
-
Madrid, SpainUniversidad Complutense de Madrid - Faculty of Psychology
Aug 23, 2022
Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Sodium Valproate
- +2 more
-
Saint Leonards, New South Wales, Australia
- +8 more
Jan 22, 2023
Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)
Recruiting
- Hepatocellular Carcinoma (HCC)
-
Kaohsiung, Taiwan
- +4 more
Mar 14, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)
Completed
- Cutaneous T Cell Lymphoma
- +2 more
-
Leeds, United KingdomCovance Clinical research Unit Ltd.
Feb 3, 2022
Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)
Active, not recruiting
- Non Small Cell Lung Cancer
- HBI-8000 in combination with pembrolizumab
-
Goodyear, Arizona
- +6 more
Dec 5, 2022
Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou
Recruiting
- Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
- Tucidinostat (chidamide) and PD-1 inhibitor (Toripalimab)
-
Guangzhou, Guangdong, ChinaCancer center of Sun Yat-sen University
Jul 20, 2022
Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)
Recruiting
- Neuroblastoma in Children
- Tucidinostat and etoposide
-
Guangzhou, ChinaSun Yat-sen University
Jun 9, 2022